$ZS

Yorkville Ives initiates Zscaler stock with outperform rating

Yorkville Ives initiated coverage on Zscaler (ZS) with an outperform rating and a $250 price target. Analysts show strong conviction with a consensus buy rating and targets ranging from $164.75 to $298. Zscaler's revenue grew 25% YoY to $3.35B, with 76.87% gross margins. The company targets $8B in annual recurring revenue by 2031, driving multiple price target increases from analysts.

Original reporting
Published Oct 7, 2026, 3:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 4:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ZS
Bullish
medium confidence
Mentioned
$ZS
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ZSBullishLow
01

Why it matters

Analyst coverage can act as a catalyst for short‑term price moves, especially when accompanied by a significant price target uplift.

02

Market read

Coverage initiation may attract new buyers, potentially boosting Zscaler's share price in the near term.

03

What to watch

Potential macro headwinds from rising yields could dampen tech valuations.

Relevance 5/10Novelty 5/10Timing: today

Background

The article reports Yorkville Ives' new coverage of Zscaler, including price target and analyst consensus, within a broader market backdrop of rising yields and oil prices.

Company-level read

Ticker impact

$ZSBullishMedium confidence
Context

Yorkville Ives initiated coverage on Zscaler with an outperform rating and a $250 price target, raising expectations for the stock.

Expected impact

likely upward pressure as investors price in the new target

Evidence & confidence

Coverage initiation and a $250 target represent a 18% upside from current price, prompting potential demand.

Market effects

Positive outlook may lift other zero‑trust and cybersecurity stocks.

U.S. tech sector could see modest gains.

Limited to investors focused on cybersecurity and cloud security markets.

Counterpoint

The target may be overly optimistic given valuation levels; price could stall.

Key entities

  • Yorkville Ives

    Initiated coverage on Zscaler with an outperform rating.

  • Zscaler Inc.

    Cybersecurity firm receiving new coverage and higher price targets.

Related articles

$ZSMed

Zscaler (ZS) Sets $8B ARR Goal by FY2031 Amid Mixed Analyst View

Zscaler (ZS) aims to reach $8B in annual recurring revenue by FY2031, a 2.4x increase from current revenue. Analysts' views are mixed, with Morgan Stanley lowering its price target to $185 and UBS raising it to $250. The company's P/S ratio is 10.14x, below its historical median of 18.9x, reflecting market skepticism about growth and profitability.

$ZSMed

ZSCALER (ZS) Maintained by JP Morgan -- Price Target Raised to $

JP Morgan maintained an Overweight rating on Zscaler (ZS) and raised its price target from $215 to $245. The company's GF Value™ suggests it is 28.2% undervalued, with a GF Score™ of 76/100. Insider selling totaled $6.4M over the past three months. Zscaler operates in cloud-native cybersecurity, serving large enterprises and government agencies.

$ZSMed

ZS Maintained by Barclays -- Price Target Raised to $225

Barclays maintained an Overweight rating for Zscaler (ZS) and raised its price target to $225 from $220. GuruFocus values ZS at $296.22, suggesting a 29.1% undervaluation at its current price of $210.08. The company has a GF Score of 76/100, indicating strong growth and valuation but low profitability. Insider selling totaled $6.4M in the last 3 months.